Amphotericin B
Mostrando 25-36 de 1327 artigos, teses e dissertações.
-
25. A case of recurrent keratitis caused by Paecilomyces lilacinus and treated by voriconazole
RESUMO | Descrevemos aqui um caso de uma mulher de 21 anos que apresentou baixa acuidade visual, dor e hiperemia no olho esquerdo por 45 dias. O olho apresentava infiltrado corneano extenso, com fusão e perfuração central colada com cianoacrilato, mas com Seidel (+). Ela foi submetida a transplante de córnea tectônica e lavagem de câmara anterior com i
Arq. Bras. Oftalmol.. Publicado em: 2019-03
-
26. Good response to pentamidine isethionate in a case of Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis that was difficult to treat: Case Report
Abstract In Brazil, meglumine antimoniate is the first drug of choice for mucosal leishmaniasis treatment followed by amphotericin B and pentamidine isethionate. We report the case of a patient with severe mucosal lesions caused by Leishmania (Viannia) braziliensis that were difficult to treat. Over a 14-year period, the patient showed low adherence and thre
Rev. Soc. Bras. Med. Trop.. Publicado em: 17/01/2019
-
27. First report of an autochthonous human visceral leishmaniasis in a child from the South of Minas Gerais State, Brazil
ABSTRACT American visceral leishmaniasis (VL) is a vector-borne disease transmitted by some species of phlebotomine sandflies from the genus Lutzomyia. This neglected tropical zoonosis shows increasing urbanization process, since the end of the 1980s. After the emergence of foci of the disease in urban areas, VL has assumed an important role in public health
Rev. Inst. Med. trop. S. Paulo. Publicado em: 20/12/2018
-
28. Antifungal susceptibility of yeasts isolated from anthropogenic watershed
Abstract Yeasts are unicellular fungi widespread in the environment, and studies suggest that there is a positive correlation between yeast and polluted aquatic environments. The aim of this study was to analyze the diversity and resistance of yeasts isolated from water samples collected along the Arroio Dilúvio in Porto Alegre to antifungals. Yeast isolate
An. Acad. Bras. Ciênc.. Publicado em: 17/12/2018
-
29. Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
Rev. Inst. Med. trop. S. Paulo. Publicado em: 08/11/2018
-
30. Neolignans isolated from twigs of Nectandra leucantha Ness & Mart (Lauraceae) displayed in vitro antileishmanial activity
Abstract Background: The therapeutic arsenal for the treatment of Leishmaniasis is limited and includes toxic compounds (antimonials, amphotericin B, pentamidine and miltefosine). Given these aspects, the search for new compounds based on floristic biodiversity is crucial. In the present work, we report the isolation, characterization and antileishmanial ac
J. Venom. Anim. Toxins incl. Trop. Dis. Publicado em: 18/10/2018
-
31. Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area
ABSTRACT Leishmaniasis is a disease complex with various clinical symptoms caused by different species of parasites of the genus Leishmania. The visceral form of the disease, characterized by severe symptoms is fatal, if not treated. The high toxicity of current antileishmanial drugs and the need for long-term treatment make the therapy complicated, especial
Rev. Inst. Med. trop. S. Paulo. Publicado em: 13/09/2018
-
32. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case
Abstract Visceral leishmaniasis is a systemic disease that is potentially severe and endemic in Brazil. It clinically manifests as fever, weight loss, swelling, hepatosplenomegaly, paleness, and edema. In this study, we discuss a case of a 1-year-old child diagnosed with refractory visceral leishmaniasis after being treated with liposomal amphotericin B in t
Rev. Soc. Bras. Med. Trop.. Publicado em: 2018-06
-
33. Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
Abstract: The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were
An. Bras. Dermatol.. Publicado em: 2018-06
-
34. Mucosal leishmaniasis: the experience of a Brazilian referral center
Abstract INTRODUCTION Pentavalent antimonials (Sbv) are the most commonly used drugs for the treatment of mucosal leishmaniasis (ML), despite their high toxicity and only moderate efficacy. The aim of this study was to report therapeutic responses with different available options for ML. METHODS This study was based on a review of clinical records of 35
Rev. Soc. Bras. Med. Trop.. Publicado em: 2018-06
-
35. The status of cryptococcosis in Latin America
Cryptococcosis is a life-threatening fungal infection caused by the encapsulated yeasts Cryptococcus neoformans and C. gattii, acquired from the environment. In Latin America, as occurring worldwide, C. neoformans causes more than 90% of the cases of cryptococcosis, affecting predominantly patients with HIV, while C. gattii generally affects otherwise health
Mem. Inst. Oswaldo Cruz. Publicado em: 05/04/2018
-
36. Visceral leishmaniasis in a Brazilian endemic area: an overview of occurrence, HIV coinfection and lethality
ABSTRACT The Brazilian municipality of Rondonópolis, Mato Grosso State, represents an important visceral leishmaniasis (VL) endemic area. This study described epidemiological and clinical aspects of the occurrence, VL/HIV coinfection and lethality related to VL in Rondonópolis. Data from autochthonous cases reported between 2011 and 2016 were obtained from
Rev. Inst. Med. trop. S. Paulo. Publicado em: 08/03/2018